LD-2 disclosure · 4th Quarter - Report
STEALTH BIOTHERAPEUTICS INC.
Income$20Kfee reported
Client
- Name
- STEALTH BIOTHERAPEUTICS INC.
- Description
- developing therapies to treat mitochondrial dysfunction
- Location
- Massachusetts · United States of America
Registrant
- Description
- lobby firm
- Location
- Washington, District of Columbia, United States of America
Lobbying activities
1 issuePharmacy
H.R.4408/S.1906, Promising Pathway Act FDA Reform H.R. 6888/S. 4071, Helping Experts Accelerate Rare Treatments (HEART) Act [117th Congress] Rare Disease Drug Development Ultra-Rare Disease Definition
LobbyistsKATHERINE LANDES · ALEXANDER ROOT
TargetedSENATE · HOUSE OF REPRESENTATIVES